BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28923854)

  • 1. Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.
    Chatterjee M; Ben-Josef E; Robb R; Vedaie M; Seum S; Thirumoorthy K; Palanichamy K; Harbrecht M; Chakravarti A; Williams TM
    Cancer Res; 2017 Nov; 77(21):5925-5937. PubMed ID: 28923854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer.
    Wolfe AR; Robb R; Hegazi A; Abushahin L; Yang L; Shyu DL; Trevino JG; Cruz-Monserrate Z; Jacob JR; Palanichamy K; Chakravarti A; Williams TM
    Clin Cancer Res; 2021 Jan; 27(2):554-565. PubMed ID: 33087331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.
    Bertino EM; Williams TM; Nana-Sinkam SP; Shilo K; Chatterjee M; Mo X; Rahmani M; Phillips GS; Villalona-Calero MA; Otterson GA
    Clin Lung Cancer; 2015 Nov; 16(6):466-74. PubMed ID: 26123189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
    Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S
    Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolae-dependent and -independent uptake of albumin in cultured rodent pulmonary endothelial cells.
    Li HH; Li J; Wasserloos KJ; Wallace C; Sullivan MG; Bauer PM; Stolz DB; Lee JS; Watkins SC; St Croix CM; Pitt BR; Zhang LM
    PLoS One; 2013; 8(11):e81903. PubMed ID: 24312378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Detection of Treatment-Induced Mitotic Arrest Using Temporal Diffusion Magnetic Resonance Spectroscopy.
    Jiang X; Li H; Zhao P; Xie J; Khabele D; Xu J; Gore JC
    Neoplasia; 2016 Jun; 18(6):387-97. PubMed ID: 27292027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
    Desai NP; Trieu V; Hwang LY; Wu R; Soon-Shiong P; Gradishar WJ
    Anticancer Drugs; 2008 Oct; 19(9):899-909. PubMed ID: 18766004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.
    Demeure MJ; Stephan E; Sinari S; Mount D; Gately S; Gonzales P; Hostetter G; Komorowski R; Kiefer J; Grant CS; Han H; Von Hoff DD; Bussey KJ
    Ann Surg; 2012 Jan; 255(1):140-6. PubMed ID: 22156929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolae may enable albumin to enter human renal glomerular endothelial cells.
    Moriyama T; Takei T; Itabashi M; Uchida K; Tsuchiya K; Nitta K
    J Cell Biochem; 2015 Jun; 116(6):1060-9. PubMed ID: 25640083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
    Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
    Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
    Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model.
    Gao M; Zhang D; Jin Q; Jiang C; Wang C; Li J; Peng F; Huang D; Zhang J; Song S
    Oncotarget; 2016 Sep; 7(36):58133-58141. PubMed ID: 27531898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
    Cullis J; Siolas D; Avanzi A; Barui S; Maitra A; Bar-Sagi D
    Cancer Immunol Res; 2017 Mar; 5(3):182-190. PubMed ID: 28108630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nab-Paclitaxel mechanisms of action and delivery.
    Yardley DA
    J Control Release; 2013 Sep; 170(3):365-72. PubMed ID: 23770008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP).
    Houghton PJ; Kurmasheva RT; Kolb EA; Gorlick R; Maris JM; Wu J; Tong Z; Arnold MA; Chatterjee M; Williams TM; Smith MA
    Pediatr Blood Cancer; 2015 Jul; 62(7):1214-21. PubMed ID: 25809532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q; Ching AK; Leung WK; Szeto CY; Ho SM; Chan PK; Yuan YF; Lai PB; Yeo W; Wong N
    Int J Oncol; 2011 Mar; 38(3):721-31. PubMed ID: 21240457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of osmotic polysorbitol-based transporter in RNAi silencing via caveolae-mediated endocytosis and COX-2 expression.
    Islam MA; Shin JY; Firdous J; Park TE; Choi YJ; Cho MH; Yun CH; Cho CS
    Biomaterials; 2012 Dec; 33(34):8868-80. PubMed ID: 22975426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolae/caveolin-1 are important modulators of store-operated calcium entry in Hs578/T breast cancer cells.
    Zhu H; Weisleder N; Wu P; Cai C; Chen JW
    J Pharmacol Sci; 2008 Feb; 106(2):287-94. PubMed ID: 18296864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline Reduces Albuminuria by Interfering with Caveolae-Mediated Endocytosis through Glomerular Endothelial and Epithelial Cells.
    Moriyama T; Karasawa K; Hasegawa F; Uchida K; Nitta K
    Am J Nephrol; 2019; 50(6):444-453. PubMed ID: 31655808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.